P2Y 12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent.

Subjects

Subjects :

Aspirin
Humans
Purinergic P2Y Receptor Antagonists
Ticagrelor
Diabetes Mellitus
Percutaneous Coronary Intervention

Details

Language :

English

ISSN :

1558-3597

Volume :

76

Issue :

10

Database :

MEDLINE

Journal :

Journal of the American College of Cardiology

Publication Type :

Editorial & Opinion

Accession number :

32883423

Full Text :

https://doi.org/10.1016/j.jacc.2020.06.075